基本信息
浏览量:136
职业迁徙
个人简介
I am group leader of the Department of Molecular Microbiology, Amsterdam Institute of Molecular and Life Sciences. The research focus of my academic group is on the mechanisms of protein trafficking in bacteria. How do proteins move towards their destination, how do they insert in membranes, how are they secreted into the environment or into the host? To elucidate these mechanisms, we use primarily biochemical and molecular biology approaches with strong links to structural biology labs.
How do proteins move towards their destination, how do they insert in membranes, how are they secreted into the environment or into the host? To elucidate these mechanisms, we use primarily biochemical and molecular biology approaches with strong links to structural biology labs.
We also always have a keen eye on potential applications of our fundamental work. These applications mostly concern the development of antibiotics and vaccines but also more efficient protein production processes for biotechnology.
For instance, based on our studies on a specific protein secretion system, we have created a platform for high density surface display of antigens for the development of live vaccines and derived Outer Membrane Vesicles (OMVs).
This exploitation is done in the context of the spin-off company Abera Bioscience of which I am CSO. Additionally, we work hard to develop inhibitors that interfere with the biogenesis of the bacterial cell envelope, inhibitors that may serve as a novel class of antibiotics.
How do proteins move towards their destination, how do they insert in membranes, how are they secreted into the environment or into the host? To elucidate these mechanisms, we use primarily biochemical and molecular biology approaches with strong links to structural biology labs.
We also always have a keen eye on potential applications of our fundamental work. These applications mostly concern the development of antibiotics and vaccines but also more efficient protein production processes for biotechnology.
For instance, based on our studies on a specific protein secretion system, we have created a platform for high density surface display of antigens for the development of live vaccines and derived Outer Membrane Vesicles (OMVs).
This exploitation is done in the context of the spin-off company Abera Bioscience of which I am CSO. Additionally, we work hard to develop inhibitors that interfere with the biogenesis of the bacterial cell envelope, inhibitors that may serve as a novel class of antibiotics.
研究兴趣
论文共 200 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Methods in molecular biology (Clifton, N.J.) (2024): 367-381
Microbiology (Reading, England)no. 6 (2024)
Dung T. Huynh, Emanuele Nolfi, Lobna Medfai,Peter van Ulsen,Wouter S. P. Jong,Alice J. A. M. Sijts,Joen Luirink
Human vaccines & immunotherapeuticsno. 1 (2024)
Dung T. T. Huynh,Wouter S. P. Jong, Manon A. H. Oudejans,H. Bart van den Berg van Saparoea,Joen Luirink,Peter van Ulsen
MEMBRANESno. 4 (2023)
Manon Beaujean,Rienke F. Uijen,Jeroen D. Langereis,David Boccara, Denise Dam,Angele Soria, Gert Veldhuis,Lucille Adam,Olivia Bonduelle,Nicole N. Van der Wel,Joen Luirink,Eric Pedruzzi,Jeroen Wissink,Marien I. de Jonge,Behazine Combadiere
Vaccineno. 13 (2023): 2270-2279
Linglei Jiang,Tom A. P. Driedonks,Wouter S. P. Jong,Santosh Dhakal,H. Bart van den Berg van Saparoea,Ioannis Sitaras,Ruifeng Zhou,Christopher Caputo,Kirsten Littlefield,Maggie Lowman,Mengfei Chen,Gabriela Lima,Olesia Gololobova,Barbara Smith,Vasiliki Mahairaki,M. Riley Richardson,Kathleen R. Mulka,Andrew P. Lane,Sabra L. Klein,Andrew Pekosz,Cory Brayton,Joseph L. Mankowski,Joen Luirink,Jason S. Villano,Kenneth W. Witwer
Journal of Extracellular Vesiclesno. 3 (2022): e12192-e12192
加载更多
作者统计
#Papers: 200
#Citation: 11218
H-Index: 59
G-Index: 100
Sociability: 6
Diversity: 3
Activity: 29
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn